Literature DB >> 2945041

Atrial natriuretic hormones--thirty years after the discovery of atrial volume receptors.

H J Kramer, B Lichardus.   

Abstract

Twenty-five years after the discoveries of the existence of atrial granules and of volume receptors in the heart atria the search for natriuretic hormones has led to the isolation and identification of the atrial natriuretic factors (ANF) now considered as a hormonal system. These peptides are probably synthesized and stored in the Golgi apparatus of cardiac myocytes and are released in response to atrial wall stretch following acute plasma volume expansion and increased central blood volume, e.g., during head-out water immersion, in arterial hypertension, or increased left and/or right atrial pressure in cardiac failure, but also possibly in response to increased frequency of myocardial contractions, e.g. in paroxysmal tachycardia. The mechanisms of the renal action of these potent natriuretic hormones are not yet precisely known. Increased GFR may contribute to the initial rise in urinary sodium excretion and increased renal medullary blood flow to the later phase of natriuresis. The proximal tubule, the thin descending and the ascending limb of Henle's loop and especially the medullary collecting tubule were so far incriminated as tubular sites of action of ANF. Finally, recycling of sodium in medullary tissue and secretion of sodium via back-flux from the interstitium into the medullary collecting tubule are postulated to result in the hypernatric urine observed after ANF administration. Direct suppression of the secretion of renin, aldosterone, vasopressin, and vasopressin-stimulated cAMP synthesis may also contribute to its diuretic, natriuretic, and antihypertensive effects. The renal hemodynamic and tubular as well as the adrenal and systemic vascular effects are related to enhanced cGMP synthesis in medium-sized arterial vessels, in glomeruli and specific tubular segments, and in adrenal tissue, and may be calcium dependent. Specific ANF-binding sites were detected in these target organs. Although increased ANF release was observed in response to atrial distension in various disease states, which may contribute to renal sodium elimination in human hypertension and congestive heart failure, further studies are needed to identify its precise physiological and pathophysiological significance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2945041     DOI: 10.1007/bf01734338

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  138 in total

1.  Alpha atrial natriuretic peptide concentrations in plasma of children with congenital heart and pulmonary diseases.

Authors:  R E Lang; T Unger; D Ganten; J Weil; F Bidlingmaier; D Dohlemann
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-02

2.  Possible role for atrial natriuretic peptide in polyuria associated with paroxysmal atrial arrhythmias.

Authors:  T Yamaji; M Ishibashi; H Nakaoka; K Imataka; M Amano; J Fujii
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

3.  The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties.

Authors:  T G Flynn; M L de Bold; A J de Bold
Journal:  Biochem Biophys Res Commun       Date:  1983-12-28       Impact factor: 3.575

Review 4.  Specific granules in mammalian and non-mammalian vertebrate cardiocytes.

Authors:  S A Bencosme; J M Berger
Journal:  Methods Achiev Exp Pathol       Date:  1971

5.  Effects of vagotomy and renal denervation on renal response to blood volume expansion.

Authors:  J W Pearce; B Lichardus
Journal:  Can J Physiol Pharmacol       Date:  1967-07       Impact factor: 2.273

6.  Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility.

Authors:  H D Kleinert; T Maack; S A Atlas; A Januszewicz; J E Sealey; J H Laragh
Journal:  Hypertension       Date:  1984 Mar-Apr       Impact factor: 10.190

7.  Effect of native and synthetic atrial natriuretic factor on cyclic GMP.

Authors:  P Hamet; J Tremblay; S C Pang; R Garcia; G Thibault; J Gutkowska; M Cantin; J Genest
Journal:  Biochem Biophys Res Commun       Date:  1984-09-17       Impact factor: 3.575

8.  Antihypertensive and aldosterone-lowering effects of synthetic atrial natriuretic factor in renin-dependent renovascular hypertension.

Authors:  M Volpe; G Odell; H D Kleinert; M J Camargot; J H Laragh; J A Lewicki; T Maack; E D Vaughan; S A Atlas
Journal:  J Hypertens Suppl       Date:  1984-12

9.  Atrial natriuretic factor in human blood.

Authors:  T Yamaji; M Ishibashi; F Takaku
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

10.  Atrial natriuretic factor--a circulating hormone stimulated by volume loading.

Authors:  R E Lang; H Thölken; D Ganten; F C Luft; H Ruskoaho; T Unger
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

View more
  3 in total

1.  Endogenous digoxin-like substance in the urine of preterm infants with late hyponatremia.

Authors:  L Kovács; J Bircák; B Lichardus
Journal:  Eur J Pediatr       Date:  1987-11       Impact factor: 3.183

2.  The intraocular pressure response of human atrial natriuretic factor in glaucoma.

Authors:  M Diestelhorst; G K Krieglstein
Journal:  Int Ophthalmol       Date:  1989-01       Impact factor: 2.031

3.  Impaired renal responsiveness to human atrial natriuretic peptide (hANP) in normotensive patients with type 1 diabetes mellitus.

Authors:  E Jungmann; M C Walter-Schräder; T Haak; W Fassbinder; G Wambach; P H Althoff; K Schöffling
Journal:  Klin Wochenschr       Date:  1988-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.